Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Juni 2022

Genmab — Juni 2022

Planlagt Fastgjort Låst Flyttet Genmab
1.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #38

    we did not have that CR yet, did we?

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #39

      No it looks like abbvie has said it in an interview with bernstein

      1 Reply Last reply
      0
      • BulderB Offline
        BulderB Offline
        Bulder
        wrote on sidst redigeret af
        #40

        Maybe it’s official tomorrow together with eha lba.

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #41

          excellent. so my guess is we are looking at roughly CR45% for patients that did not have CAR/T yet

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #42

            Yes if 40% is avg of car-t and non car-t.

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #43

              If this is true, it’s outstanding.

              1 Reply Last reply
              0
              • BulderB Offline
                BulderB Offline
                Bulder
                wrote on sidst redigeret af
                #44

                In the escalation part CR was 38%.

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #45

                  Johnson & Johnson (JNJ) CEO Joaquin Duato Presents at Bernstein 38th Annual Strategic Decisions Conference https://seekingalpha.com/article/4515795-johnson-and-johnson-jnj-ceo-joaquin-duato-presents-bernstein-38th-annual-strategic-decisions

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #46

                    Tx, It's super exciting to look at what we are doing in multiple myeloma now. When you think about the 97% response rates with cell therapy, and you think about the potential of combining cell therapy with DARZALEX and with our bispecific antibody and sequence these therapies, you could think about the day in which this incurable disease could become chronically managed.

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #47

                      Xactly Winkel’s vision years back.

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #48

                        Abbvie is at bernstein too https://news.abbvie.com/news/press-releases/abbvie-to-present-at-bernstein-38th-annual-strategic-decisions-conference.htm

                        1 Reply Last reply
                        0
                        • BulderB Offline
                          BulderB Offline
                          Bulder
                          wrote on sidst redigeret af
                          #49

                          Who finds the transcript?

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            Gasolin82
                            wrote on sidst redigeret af
                            #50

                            Påvirker ikke kursen i US.

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #51

                              Here it is https://seekingalpha.com/article/4515809-abbvie-inc-abbv-presents-bernstein-38th-annual-strategic-decisions-conference

                              1 Reply Last reply
                              0
                              • BulderB Offline
                                BulderB Offline
                                Bulder
                                wrote on sidst redigeret af
                                #52

                                Presidential symposium!

                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #53

                                  Altså blandt de 6 bedste abstracts.

                                  1 Reply Last reply
                                  0
                                  • BulderB Offline
                                    BulderB Offline
                                    Bulder
                                    wrote on sidst redigeret af
                                    #54

                                    Så fik vi det hele - før tid endda. Nice.

                                    1 Reply Last reply
                                    0
                                    • BulderB Offline
                                      BulderB Offline
                                      Bulder
                                      wrote on sidst redigeret af
                                      #55

                                      Så er spm om genmab udsender noget før eller efter kl 16 i morgen, hvor abstracts offentliggøres.

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        peter12
                                        wrote on sidst redigeret af
                                        #56

                                        So I think there are -- we have different options. Where we see epcoritamab fitting is in all lines of therapy, right? Obviously, we're starting with relapsed/refractory DLBCL, and our intention is to move to the front line and everything in between

                                        1 Reply Last reply
                                        0
                                        • BulderB Offline
                                          BulderB Offline
                                          Bulder
                                          wrote on sidst redigeret af
                                          #57

                                          Ja, man kunne blive ved at plukke guldkorn fra der transcript. Ingen tvivl nu om abbvies planer med epco.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper